Cargando…
The hidden variables problem in Alzheimer's disease clinical trial design
As the leading cause of dementia worldwide, Alzheimer's disease has garnered intense academic and clinical interest. Yet, trials in search of a disease-modifying therapy have failed overwhelmingly. We suggest that, in part, this may be attributable to the influence of disruptive variables inher...
Autores principales: | Liyanage, S. Imindu, Santos, Clarissa, Weaver, Donald F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260222/ https://www.ncbi.nlm.nih.gov/pubmed/30519628 http://dx.doi.org/10.1016/j.trci.2018.09.003 |
Ejemplares similares
-
The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's disease
por: Lopez Lopez, Cristina, et al.
Publicado: (2019) -
Misfolded amyloid-β strains and their potential roles in the clinical and pathological variability of Alzheimer’s disease
por: Kelley, Sara, et al.
Publicado: (2022) -
Recruiting to preclinical Alzheimer's disease clinical trials through registries
por: Grill, Joshua D.
Publicado: (2017) -
Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerations
por: Petersen, Ronald C., et al.
Publicado: (2023) -
The Hidden Charm of Life
por: Porcar, Manuel
Publicado: (2019)